COVID-19大流行对乳腺影像的影响:国家乳腺摄影数据库分析
基于美国放射学会国家乳腺摄影数据库2019年3月1日至2021年5月31日的数据,分析COVID-19大流行期间乳腺筛查与诊断性乳腺摄影、活检及癌症诊断量的初始下降与后续反弹。结果显示筛查乳腺摄影降幅最大(降至疫情前的36.3%),恢复期未完全回到疫情前水平(85.3%),癌症诊断在急性期显著下降且未完全反弹。
要点
- 筛查乳腺摄影量在COVID-19高峰降至疫情前的36.3%,恢复期仅回升至85.3%。
- 诊断性乳腺摄影、活检和癌症诊断在高峰分别降至57.9%、47.3%和48.7%。
- 老年女性、亚裔女性、东北部设施和学术医学中心附属设施受到不成比例的负面影响。
核心结论
- COVID-19对筛查乳腺摄影量影响最大且未恢复至疫情前水平;癌症诊断在急性期显著下降且未完全反弹,强调需针对特定患者人群和设施类型加强外展工作。
研究设计与样本
- 基于美国放射学会国家乳腺摄影数据库的回顾性分析,纳入2019年3月1日至2021年5月31日的数据,共分析5,633,783例筛查乳腺摄影、1,282,374例诊断性乳腺摄影、231,390例活检和69,657例癌症诊断,比较疫情前(2019年3月1日至5月31日)、疫情高峰(2020年3月1日至5月31日)和疫情恢复期(2021年3月1日至5月31日)三个时间段。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to quantify the initial decline and subsequent rebound in breast cancer screening metrics throughout the coronavirus disease 2019 (COVID-19) pandemic.
METHODS: Screening and diagnostic mammographic examinations, biopsies performed, and cancer diagnoses were extracted from the ACR National Mammography Database from March 1, 2019, through May 31, 2021. Patient (race and age) and facility (regional location, community type, and facility type) demographics were collected. Three time periods were used for analysis: pre-COVID-19 (March 1, 2019, to May 31, 2019), peak COVID-19 (March 1, 2020, to May 31, 2020), and COVID-19 recovery (March 1, 2021, to May 31, 2021). Analysis was performed at the facility level and overall between time periods.
RESULTS: In total, 5,633,783 screening mammographic studies, 1,282,374 diagnostic mammographic studies, 231,390 biopsies, and 69,657 cancer diagnoses were analyzed. All peak COVID-19 metrics were less than pre-COVID-19 volumes: 36.3% of pre-COVID-19 for screening mammography, 57.9% for diagnostic mammography, 47.3% for biopsies, and 48.7% for cancer diagnoses. There was some rebound during COVID-19 recovery as a percentage of pre-COVID-19 volumes: 85.3% of pre-COVID-19 for screening mammography, 97.8% for diagnostic mammography, 91.5% for biopsies, and 92.0% for cancer diagnoses. Across various metrics, there was a disproportionate negative impact on older women, Asian women, facilities in the Northeast, and facilities affiliated with academic medical centers.
CONCLUSIONS: COVID-19 had the greatest impact on screening mammography volumes, which have not returned to pre-COVID-19 levels. Cancer diagnoses declined significantly in the acute phase and have not fully rebounded, emphasizing the need to increase outreach efforts directed at specific patient population and facility types.
引用
- Grimm, Lee, Rosenberg, et al. Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database. J Am Coll Radiol. 2022. PMID: 35690079. doi:10.1016/j.jacr.2022.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。